134471-40-2Relevant articles and documents
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists
Houlihan,Cheon,Parrino,Handley,Larson
, p. 3098 - 3102 (2007/10/02)
In an effort to determine the effect of modification of the imidazo[2,1- a]isoquinoline portion of the PAF-receptor antagonist SDZ 64-412 (1), several new analogs were prepared and evaluated in vitro and in vivo. One of these, 5-[4-[2-(3,4,5-trimethoxyphe